Daiwa Securities Group’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
OCA
RCM
VCM
B
Daiwa Securities Group's BIOA Position: Q1 2026 in Review
Daiwa Securities Group sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 119 shares — an estimated $2K sold.
Daiwa Securities Group first reported a position in BIOA in Q4 2025 and held it in 1 quarter. The position peaked at $2K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.
- Daiwa Securities Group reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 119 BioAge Labs shares in Q1 2026, an estimated $2K.
- Daiwa Securities Group first reported a position in BioAge Labs in Q4 2025 and held it in 1 quarter.
- Daiwa Securities Group's BioAge Labs position peaked at $2K in Q4 2025.
- 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.